Tickerplace logo

Tickerplace

Bristol-Myers Squibb Company Ce logo

CELGRBristol-Myers Squibb Company Ce

CELGR Stock Price, Valuation & Chart | Bristol-Myers Squibb Company Ce

Compare
$0.150+0.02 (+13.85%)

At close · 02 Sept 2026, 07:59 pm

Sector: HealthcareIndustry: Drug Manufacturers - GeneralCELGR intrinsic valueCELGR calculated fair value vs price
OverviewFinancialsDividendsRatios

CELGR Historical price chart

CELGR Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization302.32M
PE Ratio0.0
EPS0.0
Trading Volume60.64K
Today's High/Low0.17/0.12
Dividend YieldN/A
52 Week High/Low0.17/0.12
Shares Outstanding2.04B
CELGR Financial Statement
CELGR Analyst ratings
CELGR Analysis & performance metrics

CELGR Company profile

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small…

CELGR Management team

CELGR Frequently asked questions

What is Bristol-Myers Squibb Company Ce (CELGR) Stock Price?

Current stock price of Bristol-Myers Squibb Company Ce (CELGR) stock is $0.150. The stock price is +13.85% higher in the session. The intraday range can be seen from this page. Volume of Bristol-Myers Squibb Company Ce (CELGR) stock is 60.64K.

Last updated at 02 Sept 2026, 07:59 pm.

Why is the Bristol-Myers Squibb Company Ce (CELGR) stock price going up or down today?

The stock price of Bristol-Myers Squibb Company Ce (CELGR) can change with earnings, company news, and overall market sentiment. Bristol-Myers Squibb Company Ce operates in the Healthcare / Drug Manufacturers - General market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Bristol-Myers Squibb Company Ce stock expensive at its current price?

Whether Bristol-Myers Squibb Company Ce looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for CELGR on this page is 0.00. EPS on this page is 0.00. Compare those figures with peers and growth expectations before deciding if the current Bristol-Myers Squibb Company Ce price is justified.

How has the stock price of Bristol-Myers Squibb Company Ce (CELGR) performed historically?

Historical performance for Bristol-Myers Squibb Company Ce (CELGR) is shown on the price chart on this page. Review multi-period moves alongside volume to see how CELGR reacted to past earnings and market events.

Should I buy Bristol-Myers Squibb Company Ce (CELGR) stock, at this price?

Buying Bristol-Myers Squibb Company Ce (CELGR) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.